13D/13G Filings - The Vanguard Group

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, ...50, 51, 52, 53, 54, ...593, 594, Next
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2024-11-12
12:26 pm
Unchanged
2024-09-30 13G Accolade, Inc.
ACCD
The Vanguard Group 4,157,154
5.190%
0
(Unchanged)
Filing
History
2024-11-12
12:14 pm
Unchanged
2024-09-30 13G 23andMe Holding Co.
ME
The Vanguard Group 15,569,830
4.580%
0
(Unchanged)
Filing
History
2024-11-12
12:14 pm
Unchanged
2024-09-30 13G Achieve Life Sciences, Inc.
ACHV
The Vanguard Group 1,940,388
5.650%
0
(Unchanged)
Filing
History
2024-11-12
12:13 pm
Unchanged
2024-09-30 13G 3D Systems Corporation
DDD
The Vanguard Group 7,492,383
5.600%
0
(Unchanged)
Filing
History
2024-11-12
12:13 pm
Unchanged
2024-09-30 13G AAON, Inc.
AAON
The Vanguard Group 6,163,650
7.600%
0
(Unchanged)
Filing
History
2024-11-12
12:13 pm
Unchanged
2024-09-30 13G ACCO Brands Corporation
ACCO
The Vanguard Group 6,263,499
6.530%
0
(Unchanged)
Filing
History
2024-11-12
12:13 pm
Unchanged
2024-09-30 13G Acelyrin, Inc.
SLRN
The Vanguard Group 4,066,989
4.070%
0
(Unchanged)
Filing
History
2024-11-12
12:12 pm
Unchanged
2024-09-30 13G 4D Molecular Therapeutics, Inc.
FDMT
The Vanguard Group 2,767,717
5.320%
0
(Unchanged)
Filing
History
2024-11-12
12:12 pm
Unchanged
2024-09-30 13G A-Mark Precious Metals, Inc.
AMRK
The Vanguard Group 1,312,460
5.710%
0
(Unchanged)
Filing
History
2024-11-07
10:52 am
Purchase
2024-10-31 13G BioCryst Pharmaceuticals, Inc.
BCRX
The Vanguard Group 20,730,939
10.020%
424,343increase
(+2.09%)
Filing
History
2024-11-07
10:52 am
Purchase
2024-10-31 13G Matador Resources Company
MTDR
The Vanguard Group 12,498,860
10.010%
1,477,868increase
(+13.41%)
Filing
History
2024-11-07
10:52 am
Purchase
2024-10-31 13G Curbline Properties Corp.
CURB
The Vanguard Group 13,210,431
12.590%
13,210,431increase
(New Position)
Filing
History
2024-11-07
10:25 am
Unchanged
2024-09-30 13G BioCryst Pharmaceuticals, Inc.
BCRX
The Vanguard Group 20,306,596
9.810%
0
(Unchanged)
Filing
History
2024-11-04
3:33 pm
Unchanged
2024-09-30 13G Theravance Biopharma, Inc.
TBPH
The Vanguard Group 2,051,689
4.190%
0
(Unchanged)
Filing
History
2024-11-04
3:32 pm
Unchanged
2024-09-30 13G Klaviyo, Inc.
KVYO
The Vanguard Group 7,075,227
9.740%
0
(Unchanged)
Filing
History
2024-11-04
3:28 pm
Unchanged
2024-09-30 13G Sage Therapeutics, Inc.
SAGE
The Vanguard Group 5,760,449
9.430%
0
(Unchanged)
Filing
History
2024-11-04
3:27 pm
Unchanged
2024-09-30 13G Virgin Galactic Holdings, Inc.
SPCE
The Vanguard Group 1,217,652
4.270%
0
(Unchanged)
Filing
History
2024-11-04
3:24 pm
Unchanged
2024-09-30 13G Stem, Inc.
STEM
The Vanguard Group 8,655,953
5.320%
0
(Unchanged)
Filing
History
2024-11-04
3:23 pm
Unchanged
2024-09-30 13G Rush Street Interactive, Inc.
RSI
The Vanguard Group 7,539,851
9.070%
0
(Unchanged)
Filing
History
2024-11-04
3:22 pm
Unchanged
2024-09-30 13G Rocket Lab USA, Inc.
RKLB
The Vanguard Group 35,527,484
7.150%
0
(Unchanged)
Filing
History
Goto Prev, 0, 1, ...50, 51, 52, 53, 54, ...593, 594, Next